Uma Borate
Clinical trials sponsored by Uma Borate, explained in plain language.
-
New hope for rare blood cancers: drug combo trial launches
Disease control Recruiting nowThis study tests a new antibody drug (axatilimab) with or without a chemotherapy-like drug (azacitidine) in people with advanced blood cancers like MPN, MPN/MDS overlap, or high-risk CMML. The goal is to find the best dose and see if the combination can shrink or control the canc…
Phase: PHASE1, PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo targets Hard-to-Treat leukemia in early trial
Disease control Recruiting nowThis early-phase study tests whether combining two targeted drugs, SNDX-5613 and gilteritinib, is safe and effective for adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to treatment. The cancer must have a FLT3 mutation plus either a…
Phase: PHASE1 • Sponsor: Uma Borate • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Can a single drug stop blood cancer before it starts?
Prevention Recruiting nowThis study tests whether the drug canakinumab can prevent blood cancer in people with a condition called CCUS, where blood counts are low and there are genetic changes that raise cancer risk. The drug works by reducing inflammation, which may be a trigger for cancer. About 110 ad…
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Prevention
Last updated May 13, 2026 16:02 UTC